As of mid-August 2026, the CDC has confirmed 2,566 measles cases in the United States, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count in over three decades. Sustained transmission from 38 new outbreaks—94% of cases outbreak-associated and mostly among unvaccinated or under-vaccinated individuals under age 20—has driven this surge, with major clusters in South Carolina, Texas, Utah, Arizona, and Pennsylvania fueled by pockets of lower MMR coverage and imported introductions. CDC surveillance shows continued weekly additions, heightening risks to the U.S. measles elimination status maintained since 2000. Traders should monitor the agency's weekly Thursday updates for case counts, outbreak linkages, and any shifts in transmission patterns through year-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis en 2026 ?
Cas de rougeole aux États-Unis en 2026 ?
$7,833,635 Vol.
$7,833,635 Vol.
31 déc. 2026
↑4,5k
54%
↑3k
94%
↑3,5k
92%
↑4k
80%
↑5k
34%
↑7,5k
12%
↑10k
6%
↑12,5k
5%
$7,833,635 Vol.
$7,833,635 Vol.
31 déc. 2026
↑4,5k
$20 Vol.
54%
↑3k
$90,415 Vol.
94%
↑3,5k
$13,530 Vol.
92%
↑4k
$222,400 Vol.
80%
↑5k
$230,696 Vol.
34%
↑7,5k
$185,064 Vol.
12%
↑10k
$6,515,826 Vol.
6%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases in the United States, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count in over three decades. Sustained transmission from 38 new outbreaks—94% of cases outbreak-associated and mostly among unvaccinated or under-vaccinated individuals under age 20—has driven this surge, with major clusters in South Carolina, Texas, Utah, Arizona, and Pennsylvania fueled by pockets of lower MMR coverage and imported introductions. CDC surveillance shows continued weekly additions, heightening risks to the U.S. measles elimination status maintained since 2000. Traders should monitor the agency's weekly Thursday updates for case counts, outbreak linkages, and any shifts in transmission patterns through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Feb 16, 2026, 11:51 AM ET
Volume
$7,833,635Date de fin
31 déc. 2026Marché ouvert
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed 2,566 measles cases in the United States, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count in over three decades. Sustained transmission from 38 new outbreaks—94% of cases outbreak-associated and mostly among unvaccinated or under-vaccinated individuals under age 20—has driven this surge, with major clusters in South Carolina, Texas, Utah, Arizona, and Pennsylvania fueled by pockets of lower MMR coverage and imported introductions. CDC surveillance shows continued weekly additions, heightening risks to the U.S. measles elimination status maintained since 2000. Traders should monitor the agency's weekly Thursday updates for case counts, outbreak linkages, and any shifts in transmission patterns through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,833,635Date de fin
31 déc. 2026Marché ouvert
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, the CDC has confirmed 2,566 measles cases in the United States, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count in over three decades. Sustained transmission from 38 new outbreaks—94% of cases outbreak-associated and mostly among unvaccinated or under-vaccinated individuals under age 20—has driven this surge, with major clusters in South Carolina, Texas, Utah, Arizona, and Pennsylvania fueled by pockets of lower MMR coverage and imported introductions. CDC surveillance shows continued weekly additions, heightening risks to the U.S. measles elimination status maintained since 2000. Traders should monitor the agency's weekly Thursday updates for case counts, outbreak linkages, and any shifts in transmission patterns through year-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes